Advantages and Disadvantages of Inclisiran: A Small Interfering Ribonucleic Acid Molecule Targeting PCSK9—A Narrative Review

As dyslipidemias remain one of the main risk factors for developing cardiovascular disease, the question of maintaining optimal lipid levels with pharmacotherapy remains a subject of interest worldwide. In contrast to conventional pharmacotherapy, human monoclonal antibodies directed against proprot...

Descripción completa

Detalles Bibliográficos
Autores principales: Merćep, Iveta, Friščić, Nikolina, Strikić, Dominik, Reiner, Željko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853778/
https://www.ncbi.nlm.nih.gov/pubmed/35237348
http://dx.doi.org/10.1155/2022/8129513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8853778/
https://www.ncbi.nlm.nih.gov/pubmed/35237348
http://dx.doi.org/10.1155/2022/8129513

Ejemplares similares